Document Type : Letter to the Editor
Authors
- Muhammad Farooq Latif
- Syed H. Tirmazy
- Dalia El-Shourbagy
- Abdul Q. Basit
- Kaltar Das
- Mohamed Omara
- Dina Hamza
- Susheel Kumar
- Nezar Ahmed Salim
- Shila Sajan
Medical Oncology Department, Dubai Hospital, Dubai, UAE
Keywords
How to cite this article:
Latif MF, Tirmazy SH, El-Shourbagy D, Basit AQ, Das K, Omara M, et al. Provision of oncology services in Dubai health authority during first wave of COVID-19 pandemic: a pragmatic approach. Middle East J Cancer. 2022;13(4):733-5. doi: 10.30476/mejc.2021. 89770.1549.
2.Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335-7. doi: 10.1016/S1470-2045(20) 30096-6.
3.Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;31(7):894-901. doi: 10.1016/j.annonc. 2020.03.296.
4.Lee LY, Cazier JB, Angelis V, Arnold R, Bisht V, Campton NA, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395(10241):1919-26. doi: 10.1016/S0140-6736(20)31173-9.